Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06288282 · ClinicalTrials.gov registry record
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
A clinical trial of Chronic Back Pain, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT06288282: Recruiting study of Chronic Back Pain, sponsored by Icahn School of Medicine at Mount Sinai.
NCT06288282 is a study of Chronic Back Pain that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 130 participants, below the 169-participant average among 7 other Chronic Back Pain trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06288282, a study of Chronic Back Pain, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.
Primary Outcome
Risk of opioid misuse with the Screener and Opioid Assessment for Patients with Pain Revised (SOAPPR). The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R) is a 24-item self-report questionnaire with total scores ranging from 0 to 24 that is used to predict risk of aberrant medication-related behaviors among chronic pain patients, with higher scores indicating higher risk of aberrant behaviors.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
New York
- Mount Sinai Pain management centers - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-12-20 |
| Est. Completion | 2025-12 |
What NCT06288282 shows while recruiting
NCT06288282 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 169-participant average among 7 other Chronic Back Pain trials with a reported enrollment target (23% lower).
The record links to 1 condition, with Chronic Back Pain appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT06288282 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06288282 about?
NCT06288282 is a clinical study titled "Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain". Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cro...
What is the current status of trial NCT06288282?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2023-12-20. Estimated completion is 2025-12.
What conditions does trial NCT06288282 study?
This clinical trial studies the following conditions: Chronic Back Pain.
What interventions are being tested in trial NCT06288282?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT06288282?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06288282 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
The Effect of Yoga Practice on Chronic Back Pain
RECRUITING · NA
-
Low Intensity Focused Ultrasound for Chronic Pain: High Resolution Targeting of The Human Insula
RECRUITING · NA
-
Virtual Reality Treatment for Adults With Chronic Back Pain (VRNT)
RECRUITING · NA
-
MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
RECRUITING · NA
-
Healing Track Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI